TRAIL and NFkappaB signaling--a complex relationship

Harald Wajant1

  • 1Department of Molecular Internal Medicine Medical Polyclinic, University of Würzburg, D-97070 Würzburg, Germany.

Vitamins and Hormones
|April 28, 2004
PubMed

Insights

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) signaling is modulated by nuclear factor-kappaB (NFkappaB). NFkappaB influences TRAIL-induced cell death and can be regulated by TRAIL, impacting cancer therapy potential.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a promising anticancer therapeutic agent that induces apoptosis in cancer cells.
  • Nuclear factor-kappaB (NFkappaB) is a key transcription factor family regulating inflammation and immunity.
  • The interplay between TRAIL and NFkappaB is crucial for understanding cell death pathways.

Purpose of the Study:

  • To elucidate the multifaceted roles of the NFkappaB pathway in TRAIL signaling.
  • To explore how NFkappaB regulates cellular sensitivity to TRAIL-induced apoptosis.
  • To investigate potential autoamplifying loops and feedback mechanisms between TRAIL and NFkappaB.

Main Methods:

  • Review of existing literature on TRAIL and NFkappaB pathways.
  • Analysis of molecular mechanisms governing TRAIL-receptor interactions.
  • Examination of NFkappaB-dependent gene regulation in response to TRAIL.

Main Results:

  • NFkappaB activation can induce antiapoptotic genes, thereby inhibiting TRAIL-mediated cell death.
  • TRAIL and its receptors can be upregulated by NFkappaB, suggesting positive feedback loops.
  • TRAIL death receptors can activate the NFkappaB pathway, creating complex signaling networks.

Conclusions:

  • NFkappaB plays a critical regulatory role in TRAIL-induced apoptosis, influencing its efficacy as an anticancer therapy.
  • Understanding the intricate crosstalk between NFkappaB and TRAIL is essential for developing effective cancer treatments.
  • The bidirectional communication between TRAIL and NFkappaB offers potential targets for therapeutic intervention.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...